DarioHealth Corp. is a global digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by data analytics, software, and personalized coaching. The Company’s platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. Its digital therapeutic platform has been designed with a user-first strategy, focusing on the user’s needs and user experience and satisfaction. Dario Blood Glucose Monitoring Starter Kit is a pocket-sized smartphone glucometer that manages diabetes in one ultra-compact device. Dario Blood Pressure Monitoring System is a blood pressure monitoring system used to measure blood pressure, which allows it to store all its user readings in the Dario App. The Dario mobile app is a complete, cloud-based solution for personal chronic condition management.
Símbolo de cotizaciónDRIO
Nombre de la empresaDarioHealth Corp
Fecha de salida a bolsaMar 08, 2013
Director ejecutivoRaphael (Erez)
Número de empleados196
Tipo de seguridadOrdinary Share
Fin del año fiscalMar 08
Dirección322 W 57Th St. #33B
CiudadNEW YORK
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal10019
Teléfono16466654667
Sitio Webhttps://shop.mydario.com/
Símbolo de cotizaciónDRIO
Fecha de salida a bolsaMar 08, 2013
Director ejecutivoRaphael (Erez)
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.

Sin datos